NEXT
PREV

REVOLUTIONIZING THE INDUSTRY WITH COLLAMER®

Collamer is a unique lens material created and used exclusively by STAAR® Surgical Company in the Visian® ICL™, the nanoFLEX™ family of IOLs and the Afinity™ IOL.

THE WORLD’S FASTEST GROWING REFRACTIVE TECHNOLOGY

With over 400,000 lenses implanted worldwide, the Visian® ICL™ is growing at a rate faster than any other refractive technology in the world today.

STAAR TORIC IOL: THE CLEAR CHOICE FOR TORIC IOLS

An exceptional balance of stability and predictability. Predictable visual outcomes, stable design, and optical quality in everything you see.

DID YOU KNOW? A VISIAN® ICL™ IS IMPLANTED EVERY 6 MINUTES

Around the globe, the Visian ICL is becoming an increasingly popular vision correction technology. So popular, in fact, that every 6 minutes a new Visian ICL is implanted.

  • Apr 23 2014

    STAAR Surgical to Host Investor Breakfast and Webcast During the ASCRS Symposium on Cataract and Refractive Surgery

    MONROVIA, Calif., April 23, 2014 /PRNewswire/ – STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and delivery systems for the eye, today announced that it is hosting an investor breakfast and webcast on Saturday, April 26 during the ASCRS Symposium on cataract and refractive surgery in Boston, MA. The meeting will feature presentations by two leading […]

  • Apr 17 2014

    STAAR Surgical Announces First Quarter 2014 Results Release Date, Conference Call and Webcast

    MONROVIA, Calif., April 17, 2014 /PRNewswire/ — STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and delivery systems for the eye, today announced that it will release its financial results for the first quarter ended April 4, 2014 on Monday, April 28, 2014 after the market close. STAAR will […]

  • Mar 17 2014

    FDA Advisory Panel Votes in Favor of STAAR Surgical’s Visian® Toric Implantable® Collamer Lens, TICL™

    First of Kind Product in the U.S. MONROVIA, Calif., March 17, 2014 /PRNewswire/ – STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye and delivery systems reported that its Visian Toric Implantable Lens or TICL received favorable votes to three questions presented to the U.S. Food and Drug Administration’s (FDA) Ophthalmic Devices Panel of the Medical […]

  • Staar MD

    PHYSICIAN RESOURCES

    STAAR MD

    Welcome to STAARMD.com, a surgeon’s source for the latest materials from STAAR® products. From the Visian ICL® to the STAAR Toric IOL, this site contains information, resources, and materials geared toward supporting practice development.

  • 1363736701img02

    CONSUMER RESOURCES

    VISIAN ICL

    Welcome to VISIANINFO.com, a consumer’s source for the latest information about STAAR’s revolutionary product, the Visian Implantable Collamer® Lens. From product information to patient testimonials, this site contains information, resources and materials geared toward helping prospective consumers learn more about the Visian ICL.